Solventum upsizes note tender offers to $2B, prices purchases at premiums

Solventum Corp

Increased aggregate cap from $1.75B to $2B; Pool 1 max raised to $1.5B and Tender SubCap to $650M.
Financing condition (sale of purification/filtration business to Thermo Fisher) has been satisfied.
Accepted ~$650M of 5.450% 2027 notes (69.35% proration) and ~$797M of 5.400% 2029 notes (61.24% proration).
In Pool 2, accepted ~$458M of 6.000% 2064 notes and ~$22M of 5.900% 2054 notes (2.58% proration).
Total consideration includes $30 per $1,000 early tender payment; settlement expected Sept. 10, 2025.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.